ATE266400T1 - Heterocyclyl sulphonamid derivate - Google Patents
Heterocyclyl sulphonamid derivateInfo
- Publication number
- ATE266400T1 ATE266400T1 AT99937599T AT99937599T ATE266400T1 AT E266400 T1 ATE266400 T1 AT E266400T1 AT 99937599 T AT99937599 T AT 99937599T AT 99937599 T AT99937599 T AT 99937599T AT E266400 T1 ATE266400 T1 AT E266400T1
- Authority
- AT
- Austria
- Prior art keywords
- sulphonamide derivatives
- heterocyclyl
- heterocyclyl sulphonamide
- relates
- derivatives
- Prior art date
Links
- 150000003456 sulfonamides Chemical class 0.000 title 1
- -1 heterocyclyl sulphonamide derivatives Chemical class 0.000 abstract 2
- 102000018899 Glutamate Receptors Human genes 0.000 abstract 1
- 108010027915 Glutamate Receptors Proteins 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
- C07D211/28—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms to which a second hetero atom is attached
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
- C07D211/76—Oxygen atoms attached in position 2 or 6
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9497898P | 1998-07-31 | 1998-07-31 | |
| PCT/US1999/017142 WO2000006158A1 (en) | 1998-07-31 | 1999-07-28 | Heterocyclyl sulphonamide derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE266400T1 true ATE266400T1 (de) | 2004-05-15 |
Family
ID=22248307
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99937599T ATE266400T1 (de) | 1998-07-31 | 1999-07-28 | Heterocyclyl sulphonamid derivate |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6358982B1 (de) |
| EP (1) | EP1100497B1 (de) |
| JP (1) | JP2002521444A (de) |
| AT (1) | ATE266400T1 (de) |
| AU (1) | AU5239999A (de) |
| CA (1) | CA2338745A1 (de) |
| DE (1) | DE69917278T2 (de) |
| ES (1) | ES2221410T3 (de) |
| WO (1) | WO2000006158A1 (de) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9702194D0 (en) * | 1997-02-04 | 1997-03-26 | Lilly Co Eli | Sulphonide derivatives |
| US6693137B1 (en) | 1998-07-31 | 2004-02-17 | Eli Lilly And Company | Sulphonamide derivatives |
| AU5235599A (en) | 1998-07-31 | 2000-02-21 | Eli Lilly And Company | N-substituted sulfonamide derivatives |
| US6358981B1 (en) | 1998-07-31 | 2002-03-19 | Eli Lilly And Company | Sulphonamide derivatives |
| NZ530385A (en) | 1999-04-30 | 2004-05-28 | Lilly Co Eli | Monofluoroalkyl derivatives |
| US6639107B1 (en) | 1999-12-08 | 2003-10-28 | Eli Lilly And Company | Cyclopentyl sulfonamide derivatives |
| DZ3344A1 (fr) | 2000-05-19 | 2001-11-29 | Lilly Co Eli | Derives de sulfonamide |
| JP2004530680A (ja) * | 2001-05-04 | 2004-10-07 | イーライ・リリー・アンド・カンパニー | ２型糖尿病治療薬製造のためのａｍｐａ受容体増強物質の使用 |
| US20040157817A1 (en) * | 2001-05-30 | 2004-08-12 | Cantell Buddy Eugene | Cycloalkenylsulfonamide derivatives |
| US20070270471A1 (en) * | 2004-08-09 | 2007-11-22 | Glaxo Group Limited | Compounds Which Potentiate Glutamate Receptor and Uses Thereof in Medicine |
| GB0818071D0 (en) * | 2008-10-02 | 2008-11-05 | Glaxo Group Ltd | Compounds |
| US20110218190A1 (en) * | 2008-11-10 | 2011-09-08 | The Regents Of The University Of California | Therapeutic uses of ampa receptor modulators for treatment of motor dysfunction |
| US20150011554A1 (en) | 2013-06-13 | 2015-01-08 | Veroscience Llc | Compositions and Methods for Treating Metabolic Disorders |
| EP3436021A4 (de) | 2016-03-29 | 2019-11-06 | RespireRx Pharmaceuticals Inc. | Zusammensetzungen und verfahren zur behandlung von aufmerksamkeitsdefizitstörungen |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5312923A (en) * | 1992-02-28 | 1994-05-17 | Merck & Co., Inc. | Process for preparing fibrinogen receptor antagonists |
| AU692438B2 (en) | 1993-03-29 | 1998-06-11 | Astrazeneca Ab | Heterocyclic derivatives as platelet aggregation inhibitors |
| DE4410822A1 (de) * | 1994-03-24 | 1995-09-28 | Schering Ag | Neue Piperidin-Derivate |
| KR19980702372A (ko) * | 1995-02-21 | 1998-07-15 | 구니이 야쓰오 | 글루타민산 수용체 작용약 |
| DE19548709A1 (de) * | 1995-12-23 | 1997-07-03 | Merck Patent Gmbh | Tyrosinderivate |
| GB9702194D0 (en) | 1997-02-04 | 1997-03-26 | Lilly Co Eli | Sulphonide derivatives |
| US6174922B1 (en) | 1998-05-11 | 2001-01-16 | Eli Lilly And Company | Sulphonamide derivatives |
| NZ530385A (en) | 1999-04-30 | 2004-05-28 | Lilly Co Eli | Monofluoroalkyl derivatives |
-
1999
- 1999-07-28 ES ES99937599T patent/ES2221410T3/es not_active Expired - Lifetime
- 1999-07-28 WO PCT/US1999/017142 patent/WO2000006158A1/en not_active Ceased
- 1999-07-28 DE DE69917278T patent/DE69917278T2/de not_active Expired - Fee Related
- 1999-07-28 AU AU52399/99A patent/AU5239999A/en not_active Abandoned
- 1999-07-28 US US09/744,460 patent/US6358982B1/en not_active Expired - Fee Related
- 1999-07-28 AT AT99937599T patent/ATE266400T1/de not_active IP Right Cessation
- 1999-07-28 CA CA002338745A patent/CA2338745A1/en not_active Abandoned
- 1999-07-28 JP JP2000562013A patent/JP2002521444A/ja not_active Withdrawn
- 1999-07-28 EP EP99937599A patent/EP1100497B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US6358982B1 (en) | 2002-03-19 |
| DE69917278T2 (de) | 2005-05-19 |
| EP1100497B1 (de) | 2004-05-12 |
| EP1100497A4 (de) | 2001-09-12 |
| DE69917278D1 (de) | 2004-06-17 |
| CA2338745A1 (en) | 2000-02-10 |
| EP1100497A1 (de) | 2001-05-23 |
| JP2002521444A (ja) | 2002-07-16 |
| AU5239999A (en) | 2000-02-21 |
| WO2000006158A1 (en) | 2000-02-10 |
| ES2221410T3 (es) | 2004-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE387435T1 (de) | Substituirte benzosulfonamide als potenzierungsmittel von glutamatrezeptoren | |
| TR200200768T2 (tr) | Yeni kuinüklidin türevleri ve bunu içeren ilaç bileşimleri | |
| EA200101177A1 (ru) | Производные индола в качестве антагонистов прогестерона | |
| ES2184149T3 (es) | Paclitaxeles 6-tio sustituidos. | |
| DE60021282D1 (de) | Carbamat-derivate als muscarin-rezeptor antonisten | |
| IL140622A0 (en) | Biphenyl sufonamide derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof | |
| TR200101412T2 (tr) | Yeni bileşikler. | |
| BR9711306A (pt) | Amino a-Úcar citotÄxico e derivados de a-Úcar correlatos de indolopirrolocarbazÄis | |
| NO20034230L (no) | 1,2,3,4-tetrahydroisokinolin-derivater som urotensin II reseptor-antagonister | |
| DE69917278D1 (de) | Heterocyclyl sulphonamid derivate | |
| DK1097173T3 (da) | Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler | |
| BR0206595A (pt) | Composto, composição farmacêutica, e uso de um composto | |
| EA200200479A1 (ru) | Новые олигосахариды, их получение и содержащие их фармацевтические композиции | |
| EP0980864A3 (de) | Sulfonamid-Derivate | |
| EA200201138A1 (ru) | Пептид, модулирующий рецептор тромбопоэтина | |
| SE9901077D0 (sv) | Novel use | |
| DE60221537D1 (de) | Pteridinon-derivate als modulatoren der chemokinrezeptor-aktivität | |
| SE9801494D0 (sv) | Novel use | |
| PT1107793E (pt) | Conjugados de dextrano-leptina, composicoes farmaceuticas e processos relacionados | |
| AU1572301A (en) | Cyclopentyl sulfonamide derivatives | |
| EA200300727A1 (ru) | Производные 2h-1-бензопирана, способы их получения и их фармацевтические композиции | |
| ATE227276T1 (de) | Neue pyrimidinderivate | |
| ATE279923T1 (de) | Urotensin-ii rezeptorantagonisten | |
| ATE229934T1 (de) | Sulfonamid-derivate | |
| TR199901380A2 (xx) | Di-ya da triazo-spiro$4,5] dekan t�revleri |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |